Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
4 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Combining PARP inhibitors and platinum-based chemotherapy in metastatic triple negative and/or BRCA-associated breast cancer.
Transl Cancer Res. 2023 Jul 31;12(7):1887-1890. doi: 10.21037/tcr-23-365. Epub 2023 Jul 3.
Transl Cancer Res. 2023.
PMID: 37588734
Free PMC article.
No abstract available.
Utility of ctDNA in predicting relapse in solid tumors after curative therapy: a meta-analysis.
Mittal A, Molto Valiente C, Tamimi F, Di Iorio M, Al-Showbaki L, Cescon DW, Amir E.
Mittal A, et al. Among authors: molto valiente c.
JNCI Cancer Spectr. 2023 Jul 3;7(4):pkad040. doi: 10.1093/jncics/pkad040.
JNCI Cancer Spectr. 2023.
PMID: 37243731
Free PMC article.
Item in Clipboard
Filling the Gap after CDK4/6 Inhibitors: Novel Endocrine and Biologic Treatment Options for Metastatic Hormone Receptor Positive Breast Cancer.
Mittal A, Molto Valiente C, Tamimi F, Schlam I, Sammons S, Tolaney SM, Tarantino P.
Mittal A, et al. Among authors: molto valiente c.
Cancers (Basel). 2023 Mar 28;15(7):2015. doi: 10.3390/cancers15072015.
Cancers (Basel). 2023.
PMID: 37046675
Free PMC article.
Review.
Item in Clipboard
Clinical benefit of cancer drugs approved in Switzerland 2010-2019.
Adam R, Tibau A, Molto Valiente C, Šeruga B, Ocaña A, Amir E, Templeton AJ.
Adam R, et al. Among authors: molto valiente c.
PLoS One. 2022 Jun 10;17(6):e0268545. doi: 10.1371/journal.pone.0268545. eCollection 2022.
PLoS One. 2022.
PMID: 35687539
Free PMC article.
Item in Clipboard
Cite
Cite